Infliximab for the treatment of Kawasaki disease

Pediatr Int. 2018 Sep;60(9):775. doi: 10.1111/ped.13663.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Child
  • Child, Preschool
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infliximab / therapeutic use*
  • Mucocutaneous Lymph Node Syndrome / drug therapy*
  • Receptors, Tumor Necrosis Factor, Type I / antagonists & inhibitors
  • Receptors, Tumor Necrosis Factor, Type I / blood

Substances

  • Antibodies, Monoclonal
  • Immunoglobulins, Intravenous
  • Receptors, Tumor Necrosis Factor, Type I
  • Infliximab